Cargando…
Renin–angiotensin system inhibitors and mortality in patients with COVID-19
Association of renin–angiotensin system inhibitors with risk of death in patients with hypertension (HTN) and coronavirus disease 2019 (COVID-19) is not well characterized. The aim of this study was to evaluate the outcomes of patients with HTN and COVID-19 with respect to different chronic antihype...
Autores principales: | Rossi, Luca, Malagoli, Alessandro, Biagi, Andrea, Zanni, Alessia, Sticozzi, Concetta, Comastri, Greta, Pannone, Luigi, Gandolfi, Stefano, Vergara, Pasquale, Villani, Giovanni Quinto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680554/ https://www.ncbi.nlm.nih.gov/pubmed/33222020 http://dx.doi.org/10.1007/s15010-020-01550-0 |
Ejemplares similares
-
Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study
por: Sisinni, Antonio, et al.
Publicado: (2021) -
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020) -
Incidence, characteristics and outcomes of out-of-hospital cardiac arrest due to ventricular fibrillation in the general population: data from a single-center long-term registry
por: Bricoli, S, et al.
Publicado: (2023) -
What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004) -
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
por: Mascolo, Annamaria, et al.
Publicado: (2021)